Severe cases of local cytokine release syndrome (CRS); craniocervical edema soon after chimeric antigen T-cell (CAR-T) therapy

Craniocervical edema appears soon after chimeric antigen receptor T-cell (CAR-T) therapy in some cases. This phenomenon is often observed right after systemic cytokine release syndrome (CRS), and it is called local CRS (L-CRS). In severe cases, L-CRS causes airway obstruction and asphyxia, but it is...

Full description

Saved in:
Bibliographic Details
Published inOxford Medical Case Reports Vol. 2025; no. 1; p. omae164
Main Authors Nakamura, Naokazu, Jo, Tomoyasu, Arai, Yasuyuki, Kitawaki, Toshio, Nishikori, Momoko, Mizumoto, Chisaki, Kanda, Junya, Yamashita, Kouhei, Nagao, Miki, Takaori-Kondo, Akifumi
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.01.2025
Subjects
Online AccessGet full text
ISSN2053-8855
2053-8855
DOI10.1093/omcr/omae164

Cover

Abstract Craniocervical edema appears soon after chimeric antigen receptor T-cell (CAR-T) therapy in some cases. This phenomenon is often observed right after systemic cytokine release syndrome (CRS), and it is called local CRS (L-CRS). In severe cases, L-CRS causes airway obstruction and asphyxia, but it is not yet well known among hematologists. In this report, we present mild and severe cases of L-CRS. Tocilizumab might have limited efficacy against L-CRS, and early administration of corticosteroids can be important. We hope that this case report raises awareness of L-CRS as an acute-onset adverse event after CAR-T therapy.
AbstractList Craniocervical edema appears soon after chimeric antigen receptor T-cell (CAR-T) therapy in some cases. This phenomenon is often observed right after systemic cytokine release syndrome (CRS), and it is called local CRS (L-CRS). In severe cases, L-CRS causes airway obstruction and asphyxia, but it is not yet well known among hematologists. In this report, we present mild and severe cases of L-CRS. Tocilizumab might have limited efficacy against L-CRS, and early administration of corticosteroids can be important. We hope that this case report raises awareness of L-CRS as an acute-onset adverse event after CAR-T therapy.Craniocervical edema appears soon after chimeric antigen receptor T-cell (CAR-T) therapy in some cases. This phenomenon is often observed right after systemic cytokine release syndrome (CRS), and it is called local CRS (L-CRS). In severe cases, L-CRS causes airway obstruction and asphyxia, but it is not yet well known among hematologists. In this report, we present mild and severe cases of L-CRS. Tocilizumab might have limited efficacy against L-CRS, and early administration of corticosteroids can be important. We hope that this case report raises awareness of L-CRS as an acute-onset adverse event after CAR-T therapy.
Craniocervical edema appears soon after chimeric antigen receptor T-cell (CAR-T) therapy in some cases. This phenomenon is often observed right after systemic cytokine release syndrome (CRS), and it is called local CRS (L-CRS). In severe cases, L-CRS causes airway obstruction and asphyxia, but it is not yet well known among hematologists. In this report, we present mild and severe cases of L-CRS. Tocilizumab might have limited efficacy against L-CRS, and early administration of corticosteroids can be important. We hope that this case report raises awareness of L-CRS as an acute-onset adverse event after CAR-T therapy.
Author Kanda, Junya
Takaori-Kondo, Akifumi
Nakamura, Naokazu
Yamashita, Kouhei
Mizumoto, Chisaki
Jo, Tomoyasu
Nishikori, Momoko
Nagao, Miki
Arai, Yasuyuki
Kitawaki, Toshio
Author_xml – sequence: 1
  givenname: Naokazu
  surname: Nakamura
  fullname: Nakamura, Naokazu
  email: n_nakamura@kuhp.kyoto-u.ac.jp
– sequence: 2
  givenname: Tomoyasu
  surname: Jo
  fullname: Jo, Tomoyasu
  email: tjoh@kuhp.kyoto-u.ac.jp
– sequence: 3
  givenname: Yasuyuki
  orcidid: 0000-0002-9662-5093
  surname: Arai
  fullname: Arai, Yasuyuki
  email: ysykrai@kuhp.kyoto-u.ac.jp
– sequence: 4
  givenname: Toshio
  surname: Kitawaki
  fullname: Kitawaki, Toshio
  email: kitawaki@kuhp.kyoto-u.ac.jp
– sequence: 5
  givenname: Momoko
  surname: Nishikori
  fullname: Nishikori, Momoko
  email: nishikor@kuhp.kyoto-u.ac.jp
– sequence: 6
  givenname: Chisaki
  surname: Mizumoto
  fullname: Mizumoto, Chisaki
  email: cmizumo@kuhp.kyoto-u.ac.jp
– sequence: 7
  givenname: Junya
  surname: Kanda
  fullname: Kanda, Junya
  email: jkanda16@kuhp.kyoto-u.ac.jp
– sequence: 8
  givenname: Kouhei
  surname: Yamashita
  fullname: Yamashita, Kouhei
  email: kouhei@kuhp.kyoto-u.ac.jp
– sequence: 9
  givenname: Miki
  surname: Nagao
  fullname: Nagao, Miki
  email: mnagao@kuhp.kyoto-u.ac.jp
– sequence: 10
  givenname: Akifumi
  surname: Takaori-Kondo
  fullname: Takaori-Kondo, Akifumi
  email: atakaori@kuhp.kyoto-u.ac.jp
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39839700$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtr3DAUhUVJadI0u66LoIsmULeS5YdMFyUMfUGgkEzX4lq-zii1pYkkD8wmvz0yMw1poN3owf3O4R7OS3JgnUVCXnP2gbNGfHSj9ukA5FXxjBzlrBSZlGV58Oh9SE5CuGGMcVFxIeULcigaKZqasSNyd4Ub9Eg1BAzU9XRwGgaqt9H9NhapxwHTiIat7bwbkZ4uLq_OPlHtwRqn0W_MzGOHI9DgnKXQR_RUr8yI3mgKNpprtHSZaRyGJD-_zJZnNK7Qw3r7ijzvYQh4sr-Pya-vX5aL79nFz28_FucXmS5kE7O8w4r3FYDue13nUna8bVpWNLJOf81YW3SsyIuSNRzyDtoSuYZOYNNJgEqLY_J557ue2hE7jTZ6GNTamxH8Vjkw6u-JNSt17TaK87qQhaiTw-newbvbCUNUowlzJLDopqAELyVngpU8oW-foDdu8jblS1QlKymZnKk3j1d62OVPNwl4vwO0dyF47B8QztTcvprbV_v2E54_wbWJEI2bA5nhX6J3O5Gb1v-3vweimMPx
CitedBy_id crossref_primary_10_1111_bjh_19992
Cites_doi 10.7759/cureus.38905
10.1111/bjh.15644
10.3348/kjr.2023.1100
10.1002/ccr3.7281
10.1007/s12185-023-03633-8
10.3389/fimmu.2021.707191
10.1111/bjh.15412
10.1182/blood-2017-03-769620
10.1016/j.bbmt.2018.12.756
10.1111/bjh.18504
10.1007/s10147-023-02334-w
10.1056/NEJMoa1709866
ContentType Journal Article
Copyright The Author(s) 2025. Published by Oxford University Press. 2025
The Author(s) 2025. Published by Oxford University Press.
The Author(s) 2025. Published by Oxford University Press. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2025. Published by Oxford University Press. 2025
– notice: The Author(s) 2025. Published by Oxford University Press.
– notice: The Author(s) 2025. Published by Oxford University Press. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID TOX
AAYXX
CITATION
NPM
K9.
NAPCQ
7X8
5PM
DOI 10.1093/omcr/omae164
DatabaseName Oxford Journals Open Access Collection
CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

ProQuest Health & Medical Complete (Alumni)
PubMed

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: TOX
  name: Oxford Journals Open Access Collection
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2053-8855
ExternalDocumentID PMC11748437
39839700
10_1093_omcr_omae164
10.1093/omcr/omae164
Genre Journal Article
Case Reports
GroupedDBID 0R~
5VS
AAFWJ
AAMVS
AAPPN
AAPXW
AAVAP
ABDBF
ABEJV
ABGNP
ABPTD
ABXVV
ACGFS
ACUHS
ADBBV
ADHZD
ADRAZ
AENZO
AFULF
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMNDL
AOIJS
BAYMD
BCNDV
BTTYL
CIDKT
DIK
EBS
EJD
GROUPED_DOAJ
H13
HYE
IAO
ITC
KQ8
KSI
M48
M~E
O9-
OAWHX
OJQWA
OK1
PEELM
RHF
ROX
RPM
TJX
TOX
AAYXX
AFPKN
CITATION
NPM
K9.
NAPCQ
7X8
5PM
ID FETCH-LOGICAL-c489t-2de61f6aacffc7288d1b9b04987fc7c00b4d04245091a2dab5e1cad3e9d8aa6c3
IEDL.DBID M48
ISSN 2053-8855
IngestDate Thu Aug 21 18:41:18 EDT 2025
Fri Jul 11 16:41:47 EDT 2025
Mon Jun 30 12:11:26 EDT 2025
Wed Feb 19 01:58:26 EST 2025
Tue Jul 01 01:26:34 EDT 2025
Thu Apr 24 22:58:11 EDT 2025
Fri Jan 31 08:06:31 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords case report
chimeric antigen receptor T cell therapy
cytokine release syndrome
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
https://creativecommons.org/licenses/by-nc/4.0
The Author(s) 2025. Published by Oxford University Press.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c489t-2de61f6aacffc7288d1b9b04987fc7c00b4d04245091a2dab5e1cad3e9d8aa6c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ORCID 0000-0002-9662-5093
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1093/omcr/omae164
PMID 39839700
PQID 3168688081
PQPubID 7089188
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11748437
proquest_miscellaneous_3158103051
proquest_journals_3168688081
pubmed_primary_39839700
crossref_primary_10_1093_omcr_omae164
crossref_citationtrail_10_1093_omcr_omae164
oup_primary_10_1093_omcr_omae164
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-01-01
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Oxford Medical Case Reports
PublicationTitleAlternate Oxf Med Case Reports
PublicationYear 2025
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Hay (2025011813275174500_ref4) 2018; 183
Inoue (2025011813275174500_ref6) 2023; 15
Crump (2025011813275174500_ref1) 2017; 130
Maude (2025011813275174500_ref3) 2018; 378
Nakanishi (2025011813275174500_ref7) 2023; 118
Ko (2025011813275174500_ref8) 2024; 25
Linera (2025011813275174500_ref9) 2023; 11
Luan (2025011813275174500_ref10) 2021; 12
Nakamura (2025011813275174500_ref11) 2023; 200
Frey (2025011813275174500_ref5) 2019; 25
Gisselbrecht (2025011813275174500_ref2) 2018; 182
Goto (2025011813275174500_ref12) 2023; 28
References_xml – volume: 15
  start-page: e38905
  year: 2023
  ident: 2025011813275174500_ref6
  article-title: Cervical local cytokine release syndrome following chimeric antigen receptor T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma
  publication-title: Cureus
  doi: 10.7759/cureus.38905
– volume: 183
  start-page: 364
  year: 2018
  ident: 2025011813275174500_ref4
  article-title: Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy
  publication-title: Br J Haematol
  doi: 10.1111/bjh.15644
– volume: 25
  start-page: 399
  year: 2024
  ident: 2025011813275174500_ref8
  article-title: CT demonstration of local cytokine-release syndrome involving the head and neck following chimeric antigen receptor T cell infusion therapy
  publication-title: Korean J Radiol
  doi: 10.3348/kjr.2023.1100
– volume: 11
  start-page: e7281
  year: 2023
  ident: 2025011813275174500_ref9
  article-title: Severe laryngeal edema after CAR-T cell treatment in a patient with multiple myeloma: a case report
  publication-title: Clin Case Rep
  doi: 10.1002/ccr3.7281
– volume: 118
  start-page: 647
  year: 2023
  ident: 2025011813275174500_ref7
  article-title: Laryngeal edema as a symptom of local cytokine release syndrome after BCMA-targeting CAR-T therapy for relapsed and refractory multiple myeloma
  publication-title: Int J Hematol
  doi: 10.1007/s12185-023-03633-8
– volume: 12
  start-page: 707191
  year: 2021
  ident: 2025011813275174500_ref10
  article-title: Case report: local cytokine release syndrome in an acute lymphoblastic Leukemia patient after treatment with chimeric antigen receptor T-cell therapy: a possible model, literature review and perspective
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.707191
– volume: 182
  start-page: 633
  year: 2018
  ident: 2025011813275174500_ref2
  article-title: How I manage patients with relapsed/refractory diffuse large B cell lymphoma
  publication-title: Br J Haematol
  doi: 10.1111/bjh.15412
– volume: 130
  start-page: 1800
  year: 2017
  ident: 2025011813275174500_ref1
  article-title: Outcomes in refractory diffuae large B-cell lymphoma: results from the international SCHOLAR-1 study
  publication-title: Blood
  doi: 10.1182/blood-2017-03-769620
– volume: 25
  start-page: e123
  year: 2019
  ident: 2025011813275174500_ref5
  article-title: Cytokine release syndrome with chimeric antigen receptor T cell therapy
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2018.12.756
– volume: 200
  start-page: e1
  year: 2023
  ident: 2025011813275174500_ref11
  article-title: Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T-cell therapy
  publication-title: Br J Haematol
  doi: 10.1111/bjh.18504
– volume: 28
  start-page: 816
  year: 2023
  ident: 2025011813275174500_ref12
  article-title: Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan
  publication-title: Int J Clin Oncol
  doi: 10.1007/s10147-023-02334-w
– volume: 378
  start-page: 439
  year: 2018
  ident: 2025011813275174500_ref3
  article-title: Tisagenlecleucel in children and young adults with B-cell lymphoblastic Leukemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1709866
SSID ssj0001361388
Score 2.2877347
Snippet Craniocervical edema appears soon after chimeric antigen receptor T-cell (CAR-T) therapy in some cases. This phenomenon is often observed right after systemic...
SourceID pubmedcentral
proquest
pubmed
crossref
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage omae164
SubjectTerms Airway management
Antigens
Biomarkers
Case Report
Case reports
Chemotherapy
Conflicts of interest
Cytokine storm
Drug dosages
Edema
Epiglottis
Fever
Intubation
Lymphatic system
Lymphocytes
Lymphoma
Medical imaging
Medical laboratories
Medicine
Monoclonal antibodies
Neurotoxicity
Stem cells
Steroids
Transplants & implants
Title Severe cases of local cytokine release syndrome (CRS); craniocervical edema soon after chimeric antigen T-cell (CAR-T) therapy
URI https://www.ncbi.nlm.nih.gov/pubmed/39839700
https://www.proquest.com/docview/3168688081
https://www.proquest.com/docview/3158103051
https://pubmed.ncbi.nlm.nih.gov/PMC11748437
Volume 2025
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1dS9xAFL1YhdIXsfZrWyu3UKFS0mY3XxNKERFFCmtBd2HfwmQ-cFET3V3Bfelv772TyeKK4ktgmRsS5kz2nJlJzgH4KrUQmpgj0FmkgzgubSCkDgmQRNmENKp1YRP9k_R4GP8ZJaMVaNNGfQdOH53acZ7UcHL54-5mvkcP_G9vhvSzvlITOkhD0v8FrBEnpTwN63uh71ZbIqItIfyb7w9PWuKkpe_c7snNh29N3qOhow1Y9_oR9xvAX8OKqTbhZd_vkL-Bf2eGBqdBRew0xdqiIytU81l9QQXIGSnUhK1TAX47OD3b_YWKOGtMXMb_HFRvtLmSOK3rCl2KOKrzsdvbQUKCDTxxEPCaP52-fxoMdrH5jmv-FoZHh4OD48BnLAQqFvks6GmTdm0qpbJWZT0GrsxLmjaIjH6rMCxj7XZHSVfInpZlYrpK6sjkWkiZqugdrFZ1ZT4AmpTmXjoPtTU6tjYsNYmZWGfs0JfHMunA97aXC-UNyDkH47JoNsKjgjEpPCYd2FlUXzfGG0_UIQH2TMlWi2bRDrCCA7tSwbkjHfiyaKZniztPVqa-5ZpEcAxbQjXvG_AXF4pykpZZGHZALA2LRQH7di-3VONz59_d7bKBa5R9fP7WP8GrHgcOuzWfLVidTW7NZ1JBs3LbrR5su2FOx8Hf0X-BYg6K
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Severe+cases+of+local+cytokine+release+syndrome+%28CRS%29%3B+craniocervical+edema+soon+after+chimeric+antigen+T-cell+%28CAR-T%29+therapy&rft.jtitle=Oxford+Medical+Case+Reports&rft.au=Nakamura%2C+Naokazu&rft.au=Jo%2C+Tomoyasu&rft.au=Arai%2C+Yasuyuki&rft.au=Kitawaki%2C+Toshio&rft.date=2025-01-01&rft.pub=Oxford+University+Press&rft.eissn=2053-8855&rft.volume=2025&rft.issue=1&rft_id=info:doi/10.1093%2Fomcr%2Fomae164&rft.externalDocID=10.1093%2Fomcr%2Fomae164
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2053-8855&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2053-8855&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2053-8855&client=summon